The MyMeds&Me team includes experts from pharmacovigilance, clinical and software development. Our experts will share their latest thinking on our blog. Planned topics include, practical impact on transformation of your drug safety, operations and technology implementation advice. 

Thank you for reading!

11 January 2016

Making the Transition from Passive to Active Pharmacovigilance

In preparation for my presentation at Pharmadanmark, I have been documenting the growing pressures on life sciences and the rapidly developing Pharmacovigilance landscape. I believe there is an imperative need to move from manual to automated PV processes to respond to these changes and to deliver higher levels of compliance & improved quality.
By Dr Andrew Rut
31 March 2015

Debating the Future of Spontaneous Reporting

At first glance, receiving an invitation to mark an important MHRA milestone with esteemed industry colleagues in Edinburgh sounded like an excellent opportunity to catch up with pharmacovigilance and regulatory colleagues. Edinburgh is just a short flight from London and the city is steeped in history, culture and science. How could I say no?
By Dr Andrew Rut
  • 1

Dr. Andrew Rut has written a new article on the power of AI in healthcare and drug development.

Welcome Tim Davis! The latest edition to our experienced board of directors.

Leading innovation in safety data capture - @mymedsandme CEO Dr Andrew Rut presenting #reportum at #DrugSafetyEU

Keep informed

For expert insight and updates from the MyMeds&Me team.

We respect your privacy and we will only use your email address for newsletters and company updates